Arrowhead Pharmaceuticals Inc

ARWR NASDAQ Healthcare & Biotech United States US04280A1007
65.92 $
0.23 %

Arrowhead Pharmaceuticals focuses on the development of drugs using RNA interference technology to treat genetic diseases.